The saga continues on haq/haq warrants:
August 02, 2007 08:04 PM Eastern Daylight Time
HAQ Special Meeting of Stockholders to Vote on Proposed Merger of HAQ and PharmAthene Adjourned to 10:00 A.M. E.T. August 3, 2007
DES MOINES, Iowa--(BUSINESS WIRE)--Healthcare Acquisition Corp. (AMEX:HAQ), a publicly-traded special purpose acquisition company, announced that it has convened and then adjourned without conducting any business, its Special Meeting of Stockholders to vote on, among other things, the proposed merger transaction with PharmAthene, Inc., a biodefense company developing and commercializing medical countermeasures against biological and chemical threats. The Special Meeting of Stockholders will reconvene at 10:00 a.m. E.T. on Friday, August 3rd at the offices of McCarter & English, LLP, 245 Park Avenue, 27th Floor, New York, NY.
The Special Meeting has been adjourned in order to allow time for the solicitation of additional proxies for the proposals before the Special Meeting.
In addition, it is anticipated that certain principal stockholders of HAQ and of PharmAthene may participate in privately negotiated purchases of shares of common stock of HAQ in transactions similar to those described in the supplement to HAQ’s proxy statement, dated August 1, 2007. However, the transactions described in the supplement to HAQ’s proxy statement provided for additional consideration to buyers under certain option and assignment agreements. No such additional consideration will be paid to the principal stockholders of HAQ and of PharmAthene in connection with their purchases.
The record date for stockholders entitled to vote at the special meeting remains the close of business on June 15, 2007. |
